Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Miguel E Moreno-Garcia"'
Autor:
Della White, Alexandra Cote-Martin, Marina Bleck, Nicole Garaffa, Abdulsalam Shaaban, Helen Wu, Dongmei Liu, David Young, Justin Scheer, Ivo C. Lorenz, Andrew Nixon, Jay S. Fine, Fergus R. Byrne, M.Lamine Mbow, Miguel E. Moreno-Garcia
Publikováno v:
Molecular Immunology. 156:31-38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::388c96d47cd24c46a48d3821afd019c6
https://doi.org/10.1016/j.molimm.2023.02.007
https://doi.org/10.1016/j.molimm.2023.02.007
Publikováno v:
The Journal of Immunology. 182:33.31-33.31
In lymphocytes, the antigen receptor utilizes a unique scaffolding molecule, CARMA1, to organize an oligomerization cascade that ultimately activates NF-kappaB. Activation of CARMA1 is characterized by conformational changes that expose binding sites
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f71692f7ec5ea085970b121fedd15850
https://doi.org/10.4049/jimmunol.182.supp.33.31
https://doi.org/10.4049/jimmunol.182.supp.33.31
Autor:
Blythe D Sather, Svitlana V Mikhalap, Miguel E Moreno-Garcia, Karen Sommer, Larysa M Shlapatska, Svetlana P Sidorenko, David J Rawlings
Publikováno v:
The Journal of Immunology. 182:88.19-88.19
Development of therapies for diffuse large B-cell lymphomas (DLBCL) requires a precise knowledge of signaling aberrations essential for tumor development. In normal B cells, the B cell receptor (BCR) initiates intracellular signals crucial for the su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcb125975863c45ec0303257bbbe6d97
https://doi.org/10.4049/jimmunol.182.supp.88.19
https://doi.org/10.4049/jimmunol.182.supp.88.19